Med School: Separating Hype from Hope in Genome Science

Genomic discoveries were supposed to transform medicine and move us to a new vision of preventive health care. But 15 years after the Human Genome Project was complete, that still hasn’t happened. Meanwhile, direct-to-consumer genetics companies are bypassing health care providers to market ancestry, disease risk, diet, exercise and even dating and wine applications directly to the public. Robert Green, one of the world’s leaders in generating the evidence-base for genomic medicine, describes what's right and what’s wrong with the genomic revolution, and how we can realize the promise of precision medicine for all.
(Underwritten by America's Biopharmaceutical Companies)

Speakers: Robert C. Green
Festival: Spotlight Health 2018

Watch and Listen: Health

Sometimes, a single data point can arouse new insights, inspire a novel problem-solving approach, encourage a career... See more
Dozens of physicians, health consultants and other medical experts have gone on the payroll at Apple and Google to... See more
A healthy community is characterized not only by the absence of illness but by attributes that promote well-being and... See more
The sequencing of the human genome – a complete map of the body’s three million base pairs – opened a window into... See more
Although infectious disease outbreaks, from influenza to Ebola, surface with alarming frequency, more than 80% of the... See more
Who is responsible for keeping us healthy? Provocative questions about responsibility, control, and power are being... See more

Pages